CLINICAL ATLAS · AREA 13

Growth / endocrine / puberty / bone

Open the exact information count, clinical terms, source boundaries, and next measurement for this area. Counts describe information availability—not prevalence.

HOW TO READ THE COUNTSOne key applies to all 15 areas.Each area places all 63 connected people into one mutually exclusive category. These groups describe the information available; they are not prevalence estimates.

A finding is reported
At least one feature is reported, without an explicitly normal or uncertain item in the same area.
A finding plus normal or uncertain information
A reported feature appears alongside an explicitly normal result or an unresolved observation.
Only explicitly normal results
The available information records a normal or negative result without a reported feature in the area.
Only uncertain information
An observation remains unresolved and no confirmed feature is recorded in the area.
Area not addressed
The available information does not answer this broad area; this is not a negative result.
AREA 13 / 15Body systems · Developmental physiology

Information available for Growth / endocrine / puberty / bone

How does growth biology change across age and physiological transition?

Growth trajectory, growth-axis, thyroid and adrenal testing, puberty, menstrual effects, bone health, fractures, connective features, and nutritional context.

Primary chapter · Growth, endocrine & bone
Information available
37 / 63
Original source documents available
11
Area not addressed
26 / 63
Counts for this area
Growth / endocrine / puberty / bone: mutually exclusive information groups for all 63 connected people, using the shared key above.
What is recordedPeople
A finding is reported18
A finding plus normal or uncertain information16
Only explicitly normal results2
Only uncertain information1
Area not addressed26
Total people63

37 with information + 26 not addressed = 63. For 11 people, at least one item in this area is supported by an original clinical or laboratory source addressing the area.

WHAT THE INFORMATION SHOWS

Growth trajectory, low-for-age bone density or fracture, thyroid and other endocrine testing, and hormone or menstrual-state change are represented, but the available information for many people does not address these areas.

HOW TO READ IT

Nutrition, mobility, antiseizure medication, puberty, additional findings, and ordinary endocrine or bone disease can affect growth and bone findings.

NEXT MEASUREMENT

Use serial growth, nutrition and mobility context, puberty and cycle timing, relevant endocrine testing, medication exposure, fracture history, and DEXA when indicated.

Clinical terms found in the available information

Growth & nutrition

  • failure to thrive
  • height and weight trajectory
  • macrocephaly or microcephaly
  • diet texture and nutrient intake
  • mobility and weight-bearing context

Endocrine & metabolic

  • growth-axis testing
  • adrenal testing
  • thyroid and bone age
  • clinically indicated metabolic assessment
  • vitamin and mineral-bone context

Puberty, bone & connective tissue

  • early puberty or adrenarche
  • menstrual- or hormone-linked change
  • contraceptive use for cycle control
  • fracture, DEXA, and bone density
  • hypermobility and connective-tissue findings
Where the information comes from and what it cannot show

WHERE THIS INFORMATION CAME FROM

  • growth chart
  • endocrine labs
  • bone imaging
  • puberty timeline
See the sitewide evidence framework →